Application value of 18F-FDG PET/CT in the diagnosis of cholangiocarcinoma
10.13491/j.issn.1004-714X.2022.04.020
- VernacularTitle:18F-FDG PET/CT诊断胆管细胞癌的应用价值
- Author:
Juanjuan FANG
1
;
Dewei SONG
1
;
Yuanwei SHAO
1
;
Shoumei YAN
2
;
Jing ZHOU
3
;
Chunyu JIAO
1
;
Tingzhou LIU
1
Author Information
1. Department of Medical Imaging, Dezhou Second People's Hospital, Dezhou 253000 China.
2. PET Center, Affiliated Cancer Hospital of Shandong First Medical University, Jinan 250000 China.
3. Department 1 of Abdominal Radiotherapy, Affiliated Cancer Hospital of Shandong First Medical University, Jinan 250000 China.
- Publication Type:OriginalArticles
- Keywords:
Cholangiocarcinoma;
18F-FDG;
PET/CT
- From:
Chinese Journal of Radiological Health
2022;31(4):488-493
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the value of 18F-FDG PET/CT in the diagnosis of cholangiocarcinoma. Methods Data were collected from 44 patients with cholangiocarcinoma who underwent PET/CT in Affiliated Cancer Hospital of Shandong First Medical University from September 2017 to October 2020. All patients underwent upper abdominal CT and MRI and whole-body PET/CT. The diagnostic value of three examinations was compared for primary lesions, recurrent lesions, and regional lymph node metastasis of cholangiocarcinoma. Results There were no significant differences in the diagnostic sensitivity of CT, MRI, and PET/CT in the primary lesions and regional lymph node metastasis of cholangiocarcinoma (P > 0.05). There were significant differences in the diagnostic sensitivity of the three examinations for recurrent cholangiocarcinoma lesions (P < 0.05). Conclusion PET/CT has high diagnostic value for recurrent lesions of cholangiocarcinoma, but the three examinations showed no significant differences in the diagnostic sensitivity for primary lesions and regional lymph node metastasis.
